Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

New insights into the molecular and epigenetic effects of antitumor Pt(IV)-valproic acid conjugates in human ovarian cancer cells.

Novohradsky V, Zerzankova L, Stepankova J, Vrana O, Raveendran R, Gibson D, Kasparkova J, Brabec V.

Biochem Pharmacol. 2015 Jun 1;95(3):133-44. doi: 10.1016/j.bcp.2015.04.003. Epub 2015 Apr 15.

PMID:
25888926
2.

Antitumor platinum(IV) derivatives of oxaliplatin with axial valproato ligands.

Novohradsky V, Zerzankova L, Stepankova J, Vrana O, Raveendran R, Gibson D, Kasparkova J, Brabec V.

J Inorg Biochem. 2014 Nov;140:72-9. doi: 10.1016/j.jinorgbio.2014.07.004. Epub 2014 Jul 15.

PMID:
25063910
3.

Mutation frequency dynamics in HPRT locus in culture-adapted human embryonic stem cells and induced pluripotent stem cells correspond to their differentiated counterparts.

Krutá M, Šeneklová M, Raška J, Salykin A, Zerzánková L, Pešl M, Bártová E, Franek M, Baumeisterová A, Košková S, Neelsen KJ, Hampl A, Dvořák P, Rotrekl V.

Stem Cells Dev. 2014 Oct 15;23(20):2443-54. doi: 10.1089/scd.2013.0611. Epub 2014 Jul 25.

4.

A dual-targeting, apoptosis-inducing organometallic half-sandwich iridium anticancer complex.

Novohradsky V, Zerzankova L, Stepankova J, Kisova A, Kostrhunova H, Liu Z, Sadler PJ, Kasparkova J, Brabec V.

Metallomics. 2014 Aug;6(8):1491-501. doi: 10.1039/c4mt00112e.

PMID:
24828756
5.

DNA binding studies and cytotoxicity of a dinuclear PtII diazapyrenium-based metallo-supramolecular rectangular box.

Terenzi A, Ducani C, Blanco V, Zerzankova L, Westendorf AF, Peinador C, Quintela JM, Bednarski PJ, Barone G, Hannon MJ.

Chemistry. 2012 Aug 27;18(35):10983-90. doi: 10.1002/chem.201201519. Epub 2012 Jul 16.

PMID:
22806942
6.

Valuable insight into the anticancer activity of the platinum-histone deacetylase inhibitor conjugate, cis-[Pt(NH3)2malSAHA-2H)].

Brabec V, Griffith DM, Kisova A, Kostrhunova H, Zerzankova L, Marmion CJ, Kasparkova J.

Mol Pharm. 2012 Jul 2;9(7):1990-9. doi: 10.1021/mp300038f. Epub 2012 May 25.

PMID:
22591133
7.

Interactions of DNA with a new platinum(IV) azide dipyridine complex activated by UVA and visible light: relationship to toxicity in tumor cells.

Pracharova J, Zerzankova L, Stepankova J, Novakova O, Farrer NJ, Sadler PJ, Brabec V, Kasparkova J.

Chem Res Toxicol. 2012 May 21;25(5):1099-111. doi: 10.1021/tx300057y. Epub 2012 Mar 28.

PMID:
22420335
8.

Cellular response to antitumor cis-Dichlorido platinum(II) complexes of CDK inhibitor Bohemine and its analogues.

Liskova B, Zerzankova L, Novakova O, Kostrhunova H, Travnicek Z, Brabec V.

Chem Res Toxicol. 2012 Feb 20;25(2):500-9. doi: 10.1021/tx200525n. Epub 2012 Feb 1.

PMID:
22250642
9.

Differences in the cellular response and signaling pathways between cisplatin and monodentate organometallic Ru(II) antitumor complexes containing a terphenyl ligand.

Kisova A, Zerzankova L, Habtemariam A, Sadler PJ, Brabec V, Kasparkova J.

Mol Pharm. 2011 Jun 6;8(3):949-57. doi: 10.1021/mp200105d. Epub 2011 Apr 19. Erratum in: Mol Pharm. 2012 Mar 5;9(3):694.

PMID:
21480648
10.

Influence of pyridine versus piperidine ligands on the chemical, DNA binding and cytotoxic properties of light activated trans,trans,trans-[Pt(N3)2(OH)2(NH3)(L)].

Westendorf AF, Zerzankova L, Salassa L, Sadler PJ, Brabec V, Bednarski PJ.

J Inorg Biochem. 2011 May;105(5):652-62. doi: 10.1016/j.jinorgbio.2011.01.003. Epub 2011 Jan 21.

PMID:
21450268
11.

Mechanistic insights into antitumor effects of new dinuclear cis Pt(II) complexes containing aromatic linkers.

Zerzankova L, Kostrhunova H, Vojtiskova M, Novakova O, Suchankova T, Lin M, Guo Z, Kasparkova J, Brabec V.

Biochem Pharmacol. 2010 Aug 1;80(3):344-51. doi: 10.1016/j.bcp.2010.04.013. Epub 2010 Apr 24.

PMID:
20399754
12.

Cytotoxicity, cellular uptake, glutathione and DNA interactions of an antitumor large-ring Pt II chelate complex incorporating the cis-1,4-diaminocyclohexane carrier ligand.

Kasparkova J, Suchankova T, Halamikova A, Zerzankova L, Vrana O, Margiotta N, Natile G, Brabec V.

Biochem Pharmacol. 2010 Feb 15;79(4):552-64. doi: 10.1016/j.bcp.2009.09.019.

PMID:
19782655
13.

Conformation and recognition of DNA modified by a new antitumor dinuclear PtII complex resistant to decomposition by sulfur nucleophiles.

Zerzankova L, Suchankova T, Vrana O, Farrell NP, Brabec V, Kasparkova J.

Biochem Pharmacol. 2010 Jan 15;79(2):112-21. doi: 10.1016/j.bcp.2009.08.009. Epub 2009 Aug 12.

14.

Cytotoxicity, cellular uptake, and DNA interactions of new monodentate ruthenium(II) complexes containing terphenyl arenes.

Bugarcic T, Nováková O, Halámiková A, Zerzánková L, Vrána O, Kaspárková J, Habtemariam A, Parsons S, Sadler PJ, Brabec V.

J Med Chem. 2008 Sep 11;51(17):5310-9. doi: 10.1021/jm8003043. Epub 2008 Aug 14.

PMID:
18702458
15.

Study of Copper and Purine-Copper Complexes on Modified Carbon Electrodes by Cyclic and Elimination Voltammetry.

Trnkova L, Zerzankova L, Dycka F, Mikelova R, Jelen F.

Sensors (Basel). 2008 Jan 24;8(1):429-444.

Supplemental Content

Loading ...
Support Center